Articles tagged with "Pharmaceutical"

Sort by

Global project to measure carbon footprint of clinical trials

October 15, 2022
A new international initiative is developing a methodology to assess the respective environmental impact of on and off-site clinical trials.

Professional rugby players may have greater neurodegenerative disease risk, suggests research

October 8, 2022
Former international rugby players included in a recent health study showed risks of neurodegenerative diseases that averaged more than 2.5 times that for the general population.

Ukraine conflict leaves a hole in clinical trials enrolment in region

October 8, 2022
Clinical trials in Ukraine and Russia have plunged by around 50% during 2022, according to the latest information examined by data analytics leader Phesi.

Quantum, click and evolution provide Nobel Science-winning ingredients 

October 5, 2022
Quantum physics, click chemistry and evolutionary breakthroughs were the dominant themes for this year’s winners of the world’s best known science accolades, the Nobel Prizes for Chemistry, Physics and Medicine/Physiology

AI-enhanced chromatography aims to boost analysis accuracy and speed

September 29, 2022
Fujitsu has signed a deal with the French firm Phytocontrol to integrate artificial intellegence to offer a faster and more accurate contamination analysis.

CCDC grants aim to inspire tomorrow’s structural chemistry pioneers

September 10, 2022
One of the world’s leading resources for structural chemistry, Cambridge Crystallographic Data Centre (CCDC), is launching a campaign “to inspire the next generation of Crystallographers”.

Biopharma lags in harnessing digitalisation suggests report

August 19, 2022
A study of leading UK and Irish firms in the life sciences and pharmaceutical sectors reveals wide differences in awareness and use of transformational digital technology.

Synthetic polymers offer means to bypass gene editing for biocatalysis

August 19, 2022
Scientists believe they have found a way to improve the efficiency of biocatalysis by avoiding the costs and time involved in gene editing methods.

Warning that 1 in 3 adults will lack higher Covid antibody levels by next vaccination round

August 12, 2022
A continued fall in the number of UK adults with higher level Covid antibody levels makes it likely that well over one third will lack this level of protection by...

Oxford spin-out MiroBio bought by biopharma leader for £0.3 billion

August 5, 2022
US biopharmaceutical giant Gilead Sciences has sealed an agreement to purchase the Oxford University spin-out MiroBio in a deal worth an estimated £332 million (USD$405 million).

Pin It on Pinterest